
Paradigm Clinical Research is proud to co-found the Association of Multisite Research Corporations (AMRC)— a transformative initiative for the clinical trial industry.
January 23, 2025 – Paradigm Clinical Research is proud to announce the launch of the Association of Multisite Research Corporations (AMRC), a transformative initiative for the clinical trial industry. Kurt Mussina, CEO of Paradigm Clinical Research, is a co-founder, highlighting our commitment to advancing the adoption of multisite clinical research corporations (MCRCs) to address long-standing challenges in clinical research.
The AMRC brings together 14 industry-leading multisite organizations to establish standardized practices and foster collaboration. This trade association aims to enhance trial execution, improve patient recruitment, and streamline regulatory compliance, ultimately delivering better outcomes for patients and sponsors.
Paradigm Clinical Research is honored to be founding members of AMRC in reshaping the clinical research landscape. Together, we are building a more efficient, inclusive, and impactful future for medical innovation.
Learn more about the AMRC and register for the upcoming webinar to hear from industry leaders about the future of clinical trials through innovation and collaboration.